JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
CALL
Bath & Body Works
BBWI
$3.76B
| $7.43M | ﹤0.01% |
507,170
+136,070
| +37% | +$1.96M |
|
2277
Associated Banc-Corp
ASB
$6.07B
| $7.42M | ﹤0.01% |
336,859
-171,784
| -34% | -$3.62M |
|
2278
Evertec
EVTC
$1.91B
| $7.42M | ﹤0.01% |
217,916
-18,126
| -8% | -$574K |
|
2279
CALL
Colgate-Palmolive
CL
$74.1B
| $7.4M | ﹤0.01% |
107,500
| – | – |
|
|
2280
PUT
Colgate-Palmolive
CL
$74.1B
| $7.4M | ﹤0.01% |
107,500
| – | – |
|
2281
NCR Voyix
VYX
$1.17B
| $7.39M | ﹤0.01% |
342,496
-26,031
| -7% | -$507K |
|
2282
PUT
United Parcel Service
UPS
$89.8B
| $7.38M | ﹤0.01% |
63,000
-32,700
| -34% | -$3.87M |
|
2283
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
| $7.35M | ﹤0.01% |
248,377
+31,327
| +14% | +$912K |
|
2284
Arch Capital
ACGL
$33.5B
| $7.31M | ﹤0.01% |
170,393
-289,822
| -63% | -$12M |
|
2285
CALL
Kinder Morgan
KMI
$71.4B
| $7.3M | ﹤0.01% |
345,000
| – | – |
|
|
2286
PUT
Kinder Morgan
KMI
$71.4B
| $7.3M | ﹤0.01% |
345,000
| – | – |
|
2287
Cato Corp
CATO
$66.7M
| $7.3M | ﹤0.01% |
419,491
-173,985
| -29% | -$3.11M |
|
2288
VanEck Morningstar Wide Moat ETF
MOAT
$12.5B
| $7.29M | ﹤0.01% |
133,038
+15,265
| +13% | +$808K |
|
2289
CALL
Editas Medicine
EDIT
$432M
| $7.28M | ﹤0.01% |
+245,800
| New | +$6.14M |
|
2290
PUT
Match Group
MTCH
$8.56B
| $7.28M | ﹤0.01% |
+88,600
| New | +$6.44M |
|
2291
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
| $7.26M | ﹤0.01% |
213,597
-61,048
| -22% | -$2.04M |
|
2292
CALL
Kroger
KR
$35.1B
| $7.25M | ﹤0.01% |
+250,000
| New | +$6.63M |
|
2293
PUT
Tenet Healthcare
THC
$21.5B
| $7.23M | ﹤0.01% |
190,000
+140,000
| +280% | +$4.19M |
|
2294
Jacobs Solutions
J
$16.8B
| $7.21M | ﹤0.01% |
97,079
-78,546
| -45% | -$5.94M |
|
2295
CBIZ
CBZ
$2.96B
| $7.21M | ﹤0.01% |
267,334
-130,737
| -33% | -$3.4M |
|
|
EMWP
2296
DELISTED
Eros Media World PLC
EMWP
| $7.2M | ﹤0.01% |
106,188
+104,992
| +8,779% | +$4.9M |
|
2297
iShares MSCI Malaysia ETF
EWM
$332M
| $7.19M | ﹤0.01% |
252,055
+221,115
| +715% | +$6.2M |
|
2298
Ichor Holdings
ICHR
$2.67B
| $7.18M | ﹤0.01% |
215,885
-60,243
| -22% | -$1.8M |
|
2299
CALL
Vertex Pharmaceuticals
VRTX
$131B
| $7.18M | ﹤0.01% |
32,800
+11,200
| +52% | +$2.27M |
|
2300
Insperity
NSP
$2.05B
| $7.17M | ﹤0.01% |
83,392
-31,603
| -27% | -$2.75M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.